Mechanistically, SIAH1 downregulation inhibits ubiquitination-mediated degradation of ZEB1, thereby enhancing ZEB1 stability to promote chemoresistance in HCC in vitro278. Here, SIAH1 is linked to hepatocellular carcinoma.